These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 98619)
21. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin. Billings RE J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524 [TBL] [Abstract][Full Text] [Related]
22. The effects of phenytoin and its metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin on cellular glucose transport. Wong HY; Chu TS; Chan YW; Fok TF; Fung LW; Fung KP; Ho YY Life Sci; 2005 Mar; 76(16):1859-72. PubMed ID: 15698863 [TBL] [Abstract][Full Text] [Related]
23. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396 [TBL] [Abstract][Full Text] [Related]
24. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues. Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471 [TBL] [Abstract][Full Text] [Related]
25. Distribution of 14C-diphenylhydantoin in pancreas islet cell and other tissues of toadfish. Ryo UY; Shaw MJ; Beierwaltes WH; Ice RD J Nucl Med; 1974 Aug; 15(8):685-7. PubMed ID: 4601700 [No Abstract] [Full Text] [Related]
26. Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog. Butler TC; Dudley KH; Johnson D; Roberts SB J Pharmacol Exp Ther; 1976 Oct; 199(1):82-92. PubMed ID: 978486 [TBL] [Abstract][Full Text] [Related]
27. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man. Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920 [TBL] [Abstract][Full Text] [Related]
28. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin. Kim PM; Winn LM; Parman T; Wells PG J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin. Kim YC; Kang HE; Lee MG Biopharm Drug Dispos; 2008 Jan; 29(1):51-61. PubMed ID: 18022993 [TBL] [Abstract][Full Text] [Related]
30. Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat. Mays DC; Nawoot S; Hilliard JB; Pacula CM; Gerber N J Pharmacol Exp Ther; 1987 Oct; 243(1):227-33. PubMed ID: 3668854 [TBL] [Abstract][Full Text] [Related]
31. The distribution of 5,5-diphenylhydantoin (DPH) and its metabolites in maternal anf fetal Rhesus monkey tissues. Gabler WL; Hubbard GL Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):222-30. PubMed ID: 4630318 [No Abstract] [Full Text] [Related]
32. The Memorial Sloan-Kettering biomedical cyclotron facility:radioisotope production and labeled compounds. Tilbury RS Prog Nucl Med; 1978; 4():100-7. PubMed ID: 415335 [No Abstract] [Full Text] [Related]
33. Relationship of molecular structure to in vivo scintigraphic distribution patterns of carbon-11 labeled compounds. 3. (11C)Hydantoins. Winstead MB; Parr SJ; Rogal MJ; Brockman PS; Lubcher R; Khentigan A; Lin TH; Lamb JF; Winchell HS J Med Chem; 1976 Feb; 19(2):279-86. PubMed ID: 1249808 [TBL] [Abstract][Full Text] [Related]
35. Identification of urinary catechol and methylated catechol metabolites of phenytoin in humans, monkeys, and dogs by GLC and GLC-mass spectrometry. Midha KK; Hindmarsh KW; McGilveray IJ; Cooper JK J Pharm Sci; 1977 Nov; 66(11):1596-602. PubMed ID: 410919 [TBL] [Abstract][Full Text] [Related]
36. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man. Maguire JH; Kraus BL; Butler TC; Dudley KH Ther Drug Monit; 1979; 1(3):359-70. PubMed ID: 555579 [TBL] [Abstract][Full Text] [Related]
37. The fate of orally administered [4-14C]phenytoin in two healthy male volunteers. Kadar D; Fecycz TD; Kalow W Can J Physiol Pharmacol; 1983 Apr; 61(4):403-7. PubMed ID: 6861002 [TBL] [Abstract][Full Text] [Related]
38. The intestinal dialysis of intravenously administered phenytoin by oral activated charcoal in rats. Arimori K; Nakano M J Pharmacobiodyn; 1987 Apr; 10(4):157-65. PubMed ID: 3656062 [TBL] [Abstract][Full Text] [Related]
39. The metabolism of 5,5-diphenylhydantoin (DPH) in nonpregnant and pregnant Rhesus monkeys. Gabler WL; Hubbard GL Arch Int Pharmacodyn Ther; 1973 May; 203(1):72-91. PubMed ID: 4199058 [No Abstract] [Full Text] [Related]
40. Metabolism of diphenylhydantoin (phenytoin) during pregnancy. Landon MJ; Kirkley M Br J Obstet Gynaecol; 1979 Feb; 86(2):125-32. PubMed ID: 427051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]